Monthly Archives: January 2022

Editorial Commentary for the manuscript entitled “Docking protein p130Cas regulates acinar to ductal metaplasia during pancreatic adenocarcinoma development and pancreatitis” A p130Cas-mediated mechanism governs acinar to ductal metaplasia and the initiation of pancreatic ductal adenocarcinoma

Posted in News | Comments Off on Editorial Commentary for the manuscript entitled “Docking protein p130Cas regulates acinar to ductal metaplasia during pancreatic adenocarcinoma development and pancreatitis” A p130Cas-mediated mechanism governs acinar to ductal metaplasia and the initiation of pancreatic ductal adenocarcinoma

INCIDENCE OF HEPATOCELLULAR CARCINOMA IN NONALCOHOLIC FATTY LIVER DISEASE

The epidemiology of hepatocellular carcinoma (HCC) is changing over time, with decreases in viral hepatitis-related cases and increases in the proportion attributed to non-viral etiologies, including non-alcoholic fatty liver disease (NAFLD). Historica… Continue reading

Posted in News | Comments Off on INCIDENCE OF HEPATOCELLULAR CARCINOMA IN NONALCOHOLIC FATTY LIVER DISEASE

The Impact of Nucleos(t)ide Analogs on Hepatitis B Virus DNA Integration: Hype or Reality?

Posted in News | Comments Off on The Impact of Nucleos(t)ide Analogs on Hepatitis B Virus DNA Integration: Hype or Reality?

Disease Monitoring in IBD: evolving principles and possibilities

Inflammatory bowel disease is a progressive and debilitating condition. Early and effective treatment utilizing a treat to target approach is key in improving patient outcomes. Therefore, proactive monitoring is essential to ensure treatment strategies… Continue reading

Posted in News | Comments Off on Disease Monitoring in IBD: evolving principles and possibilities

WHAT DOES DISEASE PROGRESSION LOOK LIKE IN ULCERATIVE COLITIS AND HOW MIGHT IT BE PREVENTED?

Ulcerative colitis (UC) has been characterized by inflammation limited to the mucosa. Although sustained and durable remission has been associated with mucosal healing, the recurrent phenomenon of persistent clinical disease activity despite mucosal he… Continue reading

Posted in News | Comments Off on WHAT DOES DISEASE PROGRESSION LOOK LIKE IN ULCERATIVE COLITIS AND HOW MIGHT IT BE PREVENTED?

AGA Clinical Practice Update on Approach to the Use of Noninvasive Colorectal Cancer Screening Options: Commentary

The purpose of this American Gastroenterological Association (AGA) Institute Clinical Practice Update Commentary is to review the available evidence and provide expert advice regarding the approach to using noninvasive colorectal cancer (CRC) screening… Continue reading

Posted in News | Comments Off on AGA Clinical Practice Update on Approach to the Use of Noninvasive Colorectal Cancer Screening Options: Commentary

In Memoriam: Alan F. Hofmann, M.D., Ph.D. May 17, 1931 – September 7, 2021

Posted in News | Comments Off on In Memoriam: Alan F. Hofmann, M.D., Ph.D. May 17, 1931 – September 7, 2021

“How to embrace gene therapy in gastroenterology”

Posted in News | Comments Off on “How to embrace gene therapy in gastroenterology”

Evaluating Eosinophilic Colitis as a Unique Disease using Colonic Molecular Profiles: A Multi-Site Study

Colonic eosinophilia, an enigmatic finding often referred to as eosinophilic colitis (EoC), is a poorly understood condition. Whether EoC is a distinct disease or a colonic manifestation of eosinophilic gastrointestinal diseases (EGIDs) or inflammatory… Continue reading

Posted in News | Comments Off on Evaluating Eosinophilic Colitis as a Unique Disease using Colonic Molecular Profiles: A Multi-Site Study

Reply to GASTRO-D-21-03047: “The insightful clarification of miR-144 mediated metabolic dysfunction”

Posted in News | Comments Off on Reply to GASTRO-D-21-03047: “The insightful clarification of miR-144 mediated metabolic dysfunction”